About
3.14USD+0.00 +0.00%
Closed • Updated at 00:23 GMT+00:00Market Cap$28.59M
Volume2.0K
Beta-0.66
RSI37.65
Gross Margin38.24%
Lisata Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 4 2026
Kuva Intends to Commence Tender Offer for Lisata Therapeutics by May 29, 2026
Mar 6 2026
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Jan 27 2026
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
Jan 21 2026
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Dec 4 2025
LSTA Releases Valuations Report on Level 3 Loans
Community Chat
Ask AI
Try asking
Google Übersetzer